Quick Search

 

 


 

 

Home > Result Summaries: Compounds > fosamprenavir > Result Summary for 112952_1

Result Summary for 112952_1

Result Summary
Protocol ID: 112952_1
Clinical Study ID: WEUSRTP775
Official Title: Demographic and clinical differences in patients receiving PI and NNRTI regimens, & Factors associated with hepatic outcomes
Phase: N/A
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: fosamprenavir
Trade/Product Name: Lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Effect of antiretroviral class on hepatotoxicity in HIV-infected patients (conference abstract). International Society for Pharmaceutical Engineering Annual Meeting 2007, Las Vegas, Nevada.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.